A specifically designed multi-biotic reduces uremic toxin generation and improves kidney function
Chronic kidney disease (CKD) is characterized by accumulation of uremic toxins (UTs), such as p-cresyl sulfate and indoxyl sulfate, generated through the transformation of tyrosine and tryptophan by the gut microbiota. Using an ex vivo Simulator of the Human Intestinal Microbial Ecosystem (SHIME) co...
Saved in:
| Main Authors: | Alice Beau, Jane Natividad, Berengère Benoit, Philippe Delerive, Stéphane Duboux, Yuan Feng, Marie Jammes, Cecile Barnel, Giuseppina Sequino, Claudie Pinteur, Griet Glorieux, Denis Fouque, Hubert Vidal, Laetitia Koppe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Gut Microbes |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2025.2531202 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Future of Uremic Toxin Management
by: Raymond Vanholder, et al.
Published: (2024-10-01) -
Uremic toxins levels are associated with miR-223 in chronic kidney disease-associated anemia
by: Emma Brisot, et al.
Published: (2025-08-01) -
Comparison of uremic toxin removal between expanded hemodialysis and high volume online hemodiafiltrations in different modes
by: Jan Biedunkiewicz, et al.
Published: (2024-11-01) -
Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD
by: Margaux Costes-Albrespic, et al.
Published: (2025-07-01) -
Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins
by: Lorenz A. Scherpinski, et al.
Published: (2025-06-01)